SAN FRANCISCO, Feb. 16, 2022 /PRNewswire/ — The global clinical decision support systems market size is expected to reach USD 8.60 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.7% from 2021 to 2028. Surging demand for quality care is one of the primary factors driving the market for clinical decision support systems (CDSS). Constant lookout for reliable technology solutions by care providers is also expected to work in favor of the market. The growing interest in enhanced medical care and efficient decision-making is projected to fuel the adoption of CDSS and EHR.
Key Insights & Findings from the report:
Read 150-page market research report, “Clinical Decision Support Systems Market Size, Share & Trends Analysis Report by Product (Standalone CDSS, Integrated EHR with CDSS), By Application, By Delivery Mode, By Component, By Region, And Segment Forecasts, 2021 – 2028“, published by Grand View Research.
Clinical Decision Support Systems Market Growth & Trends
To manage the COVID-19 pandemic, many initiatives are being undertaken by the government and community organizations to support the current healthcare system. These comprised front-line clinics by state governments, a volunteer panel of doctors, and many private telemedicine applications. CDSS is a playing a vital role during the pandemic as it is helping physicians make effective choices at the point of care. As a result, market players are capitalizing on this opportunity to address the problem and provide support to front-line doctors. For instance, in May 2020, DHIndia announced a collaboration with EHRC@IIITB and Healthelife to develop CDSS for COVID-19 screening. This collaboration also included the formation of a minimal triage application for front-line clinicians.
Decision support in critical health situations proves to be significant. Furthermore, these systems analyze patient medical records and provide a list of possible solutions from which the most appropriate is to be selected. Easy compatibility and interoperability of systems with different platforms have enhanced the growth prospects of the market. Collaborative efforts of researchers and software developers to make medical knowledge available to users are anticipated to contribute toward lucrative revenue generation over the forecast period.
At present, CDSS is being widely implemented across various healthcare functions such as diagnosis, drug prescription, and clinical investigations. The importance of CDSS has been acknowledged across several healthcare entities, including public and private healthcare sectors. Furthermore, healthcare organizations are undertaking initiatives for promoting the installation and integration of EHR and CDSS, which is expected to positively impact the market growth by encouraging hospital and healthcare groups to implement such solutions.
Market players are involved in strategic initiatives such as new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in October 2021, DreaMed Diabetes AI LTD. proclaimed that it has received FDA Clearance for its Type 2 Diabetes AI-based CDSS, thereby enhancing its offering.
Clinical Decision Support Systems Market Segmentation
Grand View Research has segmented the global clinical decision support systems market on the basis of product, application, delivery mode, component, and region:
Clinical Decision Support Systems Product Outlook (Revenue, USD Million, 2016 – 2028)
Clinical Decision Support Systems Application Outlook (Revenue, USD Million, 2016 – 2028)
Clinical Decision Support Systems Delivery Mode Outlook (Revenue, USD Million, 2016 – 2028)
Clinical Decision Support Systems Component Outlook (Revenue, USD Million, 2016 – 2028)
Clinical Decision Support Systems Regional Outlook (Revenue, USD Million, 2016 – 2028)
List of Key Players of Clinical Decision Support Systems Market
Check out more related market research studies published by Grand View Research:
Browse through Grand View Research’s coverage of the Healthcare IT Industry
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Grand View Compass | Grand View Pipeline
Follow Us: LinkedIn | Twitter
View original content:https://www.prnewswire.com/news-releases/clinical-decision-support-systems-market-size-worth-8-60-billion-by-2028-grand-view-research-inc-301483504.html
SOURCE Grand View Research, Inc.
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for…
BEIJING, July 3, 2024 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), a…
MILWAUKEE, July 3, 2024 /PRNewswire/ -- The U.S. Economic Development Administration (EDA) has awarded $49…
TORONTO, ON / ACCESSWIRE / July 3, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF)…
Toronto, Ontario--(Newsfile Corp. - July 3, 2024) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind"…
VRCCO veterinarians serve beer at Ponch's Place for "Meet the Vet" nightsBEND, OR / ACCESSWIRE…